All In Biotech

Drug Trial Radar · NCT07484204

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

An Open-label, Multicenter Study to Determine the Pharmacokinetics, Safety, and Tolerability of AX251 Long-Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Sep 14, 2026

Primary completion

Jul 2028

Study completion Jul 2028

Sponsor

Lead sponsor
Anxo Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Mar 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the pharmacokinetics (PK), safety, and tolerability of AX251 long-acting injectable (LAI) administered as a single dose in patients with schizophrenia. The study will include sequential dose-escalation cohorts to evaluate different dose levels of AX251 LAI.

Conditions

  • Schizophrenia

Interventions

  • AX251 LAI 45 mgDrug

    Cariprazine 45 mg

  • AX251 LAI 90 mgDrug

    Cariprazine 90 mg

  • AX251 LAI 135 mgDrug

    Cariprazine 135 mg

  • AX251 LAI 180 mgDrug

    Cariprazine 180 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetic ParameterTime frame: Day 1 pre-dose and 1, 2, 3, 4, 8, 12, and 24 hours post-dose. Days 3, 5, 7, 14, 21, 28, 42, 56, and 70

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • DHS Multispeciality Hospital

    Ahmedabad, India · Recruiting

  • Health Hospital

    Ahmedabad, India · Recruiting

  • Divine Multispeciality Hospital

    Gandhinagar, India · Recruiting

  • Ratandeep Multispeciality Hospital

    Nagar, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.